Sofosbuvir based treatment of chronic hepatitis C genotype 3 infections—A Scandinavian real-life study.

MLA

Dalgard, Olav, et al. “Sofosbuvir Based Treatment of Chronic Hepatitis C Genotype 3 Infections—A Scandinavian Real-Life Study.” PLoS ONE, vol. 12, no. 7, July 2017, pp. 1–8. EBSCOhost, https://doi.org/10.1371/journal.pone.0179764.

APA

Dalgard, O., Weiland, O., Noraberg, G., Karlsen, L., Heggelund, L., Färkkilâ, M., Balslev, U., Belard, E., Øvrehus, A., Skalshøi Kjær, M., Krarup, H., Thorup Røge, B., Hallager, S., Madsen, L. G., Lund Laursen, A., Lagging, M., & Weis, N. (2017). Sofosbuvir based treatment of chronic hepatitis C genotype 3 infections—A Scandinavian real-life study. PLoS ONE, 12(7), 1–8. https://doi.org/10.1371/journal.pone.0179764

Chicago

Dalgard, Olav, Ola Weiland, Geir Noraberg, Lars Karlsen, Lars Heggelund, Martti Färkkilâ, Ulla Balslev, et al. 2017. “Sofosbuvir Based Treatment of Chronic Hepatitis C Genotype 3 Infections—A Scandinavian Real-Life Study.” PLoS ONE 12 (7): 1–8. doi:10.1371/journal.pone.0179764.